Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 8/20 | 0.53 |
| ▸ | GSK3B | P49841 | 8/20 | 0.53 |
| ▸ | MEN1 | O00255 | 7/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.53 |
| ▸ | GAA | P10253 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | RECQL | P46063 | 4/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | THRB | P10828 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7667055 | 0.82 | GSK3A (0.55) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL8567468 | 0.80 | GSK3A (0.46) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL3062340 | 0.77 | GSK3A (0.62) | GSK3AGSK3BMEN1KMT2AGAA | |
| SCHEMBL23930054 | 0.74 | — | — | |
| SCHEMBL6417260 | 0.74 | — | — | |
| SCHEMBL367565 | 0.74 | — | — | |
| SCHEMBL7478193 | 0.74 | — | — | |
| SCHEMBL28604051 | 0.73 | MAPT (0.50) | GSK3AGSK3BMEN1KMT2AGAA | |
| Ammonia Solution, Strong SCHEMBL28792111 | 0.72 | GSK3A (0.56) | GSK3AGSK3BMEN1KMT2AGAA | |
| Hydrochloric Acid SCHEMBL7533652 | 0.72 | GSK3A (0.56) | GSK3AGSK3BMEN1KMT2AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023122956-A1 | ELECTROLYTE, ELECTROCHEMICAL APPARATUS CONTAINING SAME AND ELECTRONIC APPARATUS | 宁德新能源科技有限公司 | 2023-07-06 | — | — | WO | disclosed |
| US-20130209361-A1 | PROCESS FOR PRODUCING RADIOHALOGENATED BIOCONJUGATES AND PRODUCTS THEREOF | UCL BUSINESS PLC (GB) | 2013-08-15 | — | — | US | disclosed |
| EP-2605800-A1 | PROCESS FOR PRODUCING RADIOHALOGENATED BIOCONJUGATES AND PRODUCTS THEREOF | UCL Business PLC (GB) | 2013-06-26 | — | — | EP | disclosed |
| WO-2012022932-A1 | PROCESS FOR PRODUCING RADIOHALOGENATED BIOCONJUGATES AND PRODUCTS THEREOF | UCL BUSINESS PLC (GB) | 2012-02-23 | — | — | WO | disclosed |
| WO-2007074390-A2 | PROCESS FOR PREPARING RHODANINE-3-ACETIC ACID: A KEY INTERMEDIATED OF EPALRESTAT | KHAMAR BAKULESH MAFATLAL (IN) | 2007-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130209361-A1 | PROCESS FOR PRODUCING RADIOHALOGENATED BIOCONJUGATES AND PRODUCTS THEREOF | QPCT, CBR3, SSTR5 | GSK3A 3750/4885GSK3B 3338/4885MEN1 495/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.